Towards Healthcare
Huntington's Disease Treatment Market Size Envisioned at USD 1,217.10 Million ...

Huntington's Disease Treatment Market Size Envisioned at USD 1,217.10 Million by 2032

Status: Published Category: Therapeutic Area Insight Code: 5100 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Huntington's Disease Treatment Market Assessment

  • Overview
  • Global Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Diagnosis Type (2021 – 2033)
    • Diagnostic Imaging
    • Genetic Testing
    • Others
  • Global Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Drug Type (2021 – 2033)
    • Tetrabenazine
    • Deutetrabenazine
    • Other Drugs
  • Global Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
    • Symptomatic Therapy
    • Disease-Modifying Therapy
    • Others
  • Global Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • The Middle East and Africa

North America Huntington's Disease Treatment Market Assessment

  • Overview
  • North America Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Diagnosis Type (2021 – 2033)
    • Diagnostic Imaging
    • Genetic Testing
    • Others
  • North America Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Drug Type (2021 – 2033)
    • Tetrabenazine
    • Deutetrabenazine
    • Other Drugs
  • North America Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
    • Symptomatic Therapy
    • Disease-Modifying Therapy
    • Others

Europe Huntington's Disease Treatment Market Assessment

  • Overview
  • Europe Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Diagnosis Type (2021 – 2033)
    • Diagnostic Imaging
    • Genetic Testing
    • Others
  • Europe Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Drug Type (2021 – 2033)
    • Tetrabenazine
    • Deutetrabenazine
    • Other Drugs
  • Europe Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
    • Symptomatic Therapy
    • Disease-Modifying Therapy
    • Others

Asia-Pacific Huntington's Disease Treatment Market Assessment

  • Overview
  • Asia-Pacific Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Diagnosis Type (2021 – 2033)
    • Diagnostic Imaging
    • Genetic Testing
    • Others
  • Asia-Pacific Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Drug Type (2021 – 2033)
    • Tetrabenazine
    • Deutetrabenazine
    • Other Drugs
  • Asia-Pacific Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
    • Symptomatic Therapy
    • Disease-Modifying Therapy
    • Others

Latin America Huntington's Disease Treatment Market Assessment

  • Overview
  • Latin America Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Diagnosis Type (2021 – 2033)
    • Diagnostic Imaging
    • Genetic Testing
    • Others
  • Latin America Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Drug Type (2021 – 2033)
    • Tetrabenazine
    • Deutetrabenazine
    • Other Drugs
  • Latin America Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
    • Symptomatic Therapy
    • Disease-Modifying Therapy
    • Others

The Middle East and Africa Huntington's Disease Treatment Market Assessment

  • Overview
  • The Middle East and Africa Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Diagnosis Type (2021 – 2033)
    • Diagnostic Imaging
    • Genetic Testing
    • Others
  • The Middle East and Africa Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Drug Type (2021 – 2033)
    • Tetrabenazine
    • Deutetrabenazine
    • Other Drugs
  • The Middle East and Africa Huntington's Disease Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
    • Symptomatic Therapy
    • Disease-Modifying Therapy
    • Others

Company Profiles

  • Apitex Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Teva Pharmaceuticals Industries
  • Athena Diagnostic
  • Alnylam Pharmaceuticals
  • Elekta AB
  • Pfizer Inc.
  • SOM BIOTECH
  • Armata Pharmaceuticals, Inc.
  • H. Lundbeck A/S
  • Fulgent Genetics

Conclusion & Recommendations

  • Insight Code: 5100
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: January 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

Proceed To Buy

USD 3800
USD 2900
USD 1900
USD 5500

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

Talk to us
FAQ's

Huntingtons disease (HD) is a neurodegenerative disorder with symptoms affecting both the body and mind. Manifesting in adulthood includes hallmark motor symptoms like involuntary dance-like movements (chorea) and cognitive challenges such as difficulty thinking and concentrating. Psychiatric symptoms like depression and anxiety, along with behavioral changes and cognitive decline, contribute to the complexity of HD. The condition is progressive, varying in the rate and severity of symptoms among individuals. Emotional and social challenges are shared, underscoring the importance of early diagnosis and comprehensive care for individuals and their families.

Current treatments focus on symptom management, including medications for chorea, depression, anxiety and mood swings. Physical, occupational and speech therapies help address motor and communication difficulties. Supportive care, including emotional and psychological support, is crucial for individuals and their families, often provided through support groups and counseling. Ongoing research involves clinical trials exploring potential disease-modifying therapies to alter HDs course. It is important to note that HD research and treatment may have advanced since then and consulting healthcare professionals for the latest information is recommended.

Prominent pharmaceutical and biotech companies worldwide, including those in the United States, Europe and Asia, actively participate in huntingtons disease research and treatment development. Clinical trials, research initiatives and advancements in therapeutic approaches are distributed globally.

World Health Organization, American Society of Huntingtons Disease, National Institute of Health, Food and Drug Administration, Center for Disease Control and Prevention.
Any Questions

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 508

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 508